De Novo Antibody Drug Discovery & Development - A Chai-2 Case Study
De Novo Antibody Drug Discovery & Development -
A Chai-2 Case Study
Use the arrow buttons to preview report pages
Download Our Report To:
- Gain Exclusive Insights to Patsnap's Lao Tzu Antibody-Antigen Dataset
An innovative hybrid approach combining AI-driven analysis with manual annotation to enable efficient and high-quality collection of large-scale datasets which in turn helps to enhance the efficiency and accuracy of AI-driven antibody design and sequence optimization.
- Understand the Benefits and Limitations of Diffusion Models in De Novo Antibody Discovery and Development
Diffusion models have outperformed conventional approaches in applications such as de novo protein design and demonstrated exceptional performance across diverse domains but several limitations remain.
- Find Out How Chai-2 Contributes Significantly to Antibody Design
Chai-2 enables the de novo generation of protein sequences with stable 3D structures and well-defined functional sites, without reliance on existing antibody databases or high-throughput screening techniques.
.png?width=5501&height=1046&name=Patsnap_Logo-01%20(1).png "Patsnap_Logo-01 (1)"){kind=logo}